Clinical Study
Grade 2 Spondylolisthesis at L4-5 Treated by XLIF: Safety and Midterm Results in the “Worst Case Scenario”
Table 1
Patient demographics of grade II spondylolisthesis patients treated with extreme lateral interbody fusion (XLIF).
| | Characteristic | Statistic () |
| | Mean age in years (range) | 66.4 (25–88) | | Number of females (%) | 53 (84.1) | | Mean body mass index (BMI) (range) | 30.8 (16.9–48.4) | | Comorbidities | | | Tobacco use (%) | 47 (74.6) | | Coronary artery disease (%) | 39 (61.9) | | Diabetes (%) | 9 (14.3) | Chronic obstructive pulmonary
disease (COPD) (%) | 3 (4.8) | | Preoperative steroid use (%) | 9 (14.3) | | Cancer (%) | 7 (11.1) | | Any prior lumbar surgery (%) | 45 (71.4) | | Prior surgery type | | | Laminectomy (%) | 11 (61.1) | | Fusion (%) | 4 (22.2) | Anterior lumbar interbody fusion
(ALIF) | 3 (16.7) | | Diagnoses (primary only) | | | Spondylolisthesis (%) | 45 (71.4) | | Stenosis with instability (%) | 132 (46.6) | | Degenerative scoliosis (%) | 2 (3.2) |
|
|
